Evaluation of SPN-812 (Viloxazine Extended-release Capsule) High Dose in Children With ADHD
Public ClinicalTrials.gov record NCT03247543. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) 200 and 400 mg Efficacy and Safety in Children With ADHD - A Double-Blind, Placebo-Controlled, Pivotal Trial
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the efficacy and safety of high doses of SPN 812 in children with ADHD
Study identification
- NCT ID
- NCT03247543
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 313 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Years to 11 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2017 (Actual)
- Primary completion
- Oct 17, 2018 (Actual)
- Completion
- Oct 17, 2018 (Actual)
- Last update posted
- Jul 8, 2021
2017 – 2018
United States locations
- U.S. sites
- 10
- U.S. states
- 7
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alliance for Wellness | Long Beach | California | 90807 | — |
| Innovative Clinical Research, Inc | Lauderhill | Florida | 33319 | — |
| APG Research, LLC | Orlando | Florida | 32803 | — |
| University of South Florida- Dept. of Psychiatry and Neurosciences | Tampa | Florida | 33613 | — |
| Psychiatric Associates | Overland Park | Kansas | 66211 | — |
| Paradigm Research Professionals | Oklahoma City | Oklahoma | 73118 | — |
| Carolina Clinical Trials, Inc. | Charleston | South Carolina | 29407 | — |
| BioBehavioral Research of Austin P.C. | Austin | Texas | 78759 | — |
| Bayou City Research Corporation | Houston | Texas | 77006 | — |
| Ericksen Research & Development | Clinton | Utah | 84015 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03247543, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 8, 2021 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03247543 live on ClinicalTrials.gov.